Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
Open accessThe DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.
Abstract
Earlier research primarily attributed the effects of mesenchymal stem cell (MSC) therapies to their capacity for local engrafting and differentiating into multiple tissue types. However, recent studies have revealed that implanted cells do not survive for long, and that the benefits of MSC therapy could be due to the vast array of bioactive factors they produce, which play an important role in the regulation of key biologic processes. Secretome derivatives, such as conditioned media or exosomes, may present considerable advantages over cells for manufacturing, storage, handling, product shelf life and their potential as a ready-to-go biologic product. Nevertheless, regulatory requirements for manufacturing and quality control will be necessary to establish the safety and efficacy profile of these products. Among MSCs, human uterine cervical stem cells (hUCESCs) may be a good candidate for obtaining secretome-derived products. hUCESCs are obtained by Pap cervical smear, which is a less invasive and painful method than those used for obtaining other MSCs (for example, from bone marrow or adipose tissue). Moreover, due to easy isolation and a high proliferative rate, it is possible to obtain large amounts of hUCESCs or secretome-derived products for research and clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., Deans, R. J., Keating, A., Prockop, D. J., & Horwitz, E. M. (2006) · Cytotherapy · doi:10.1080/14653240600855905 · Cited by 17,766 · cited 1×
“The Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy established in 2006 the minimal identifying characteristics for human MSCs [29]: (a) plastic-adherent cells when maintained in standard culture conditions; (b) expression of CD105, CD73 and CD90, and lack expression of CD4…”
BackgroundValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo
Gronthos, S., Mankani, M., Brahim, J., Robey, P. G., & Shi, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240309797 · Cited by 4,570 · cited 1×
“They have also been isolated from other adult tissues such as adipose tissue [10], skin [11], lung [12], synovial membrane [13], dental pulp [14], nasal olfactory mucosa [15], breast milk [16], scalp tissue [17], muscle [18], periosteum [19], corneal limbus [20], peripheral blood [21], endometrial and menstrual blood…”
BackgroundA perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991 · cited 1×
“All of these MCSs can be isolated and expanded from stroma of many tissues, the bone marrow and subcutaneous fat being the preferred sources [28].”
BackgroundDi Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226 · cited 1×
“found that MSCs inhibit proliferation of CD4+ and CD8+ T cells [78].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734 · cited 1×
“The most promising potential applications involve the treatment of graft versus host disease [74,75], as well as of autoimmune and inflammatory diseases, such as insulin systemic lupus erythematosus (SLE), diabetes mellitus type I, (SLE), multiple sclerosis or Crohn’s”
BackgroundFriedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970) · Cell Proliferation · doi:10.1111/j.1365-2184.1970.tb00347.x · Cited by 2,724 · cited 1×
“[9], who described a fibroblast-like population able to secrete growth factors and cytokines relevant for hematopoiesis and others processes.”
BackgroundNémeth, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302 · cited 1×
“This is relevant because CAFs, a prevailing component of tumor stroma, contribute to tumor growth, invasion and dissemination [145,146].”
Background
Research works printed but not linked: 1
- 95. Litwack G. Human Biochemistry and Disease. Academic Press; Cambridge, MA, USA: 2008.
Cited by
Items 901–1,000 of 1,000
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Mediators of Anti-inflammatory Effects
Conrad, S., Younsi, A., Bauer, C., Geburek, F., & Skutella, T. (2019) · Stem cells in clinical applications · doi:10.1007/978-3-030-23421-8_6 · Cited by 5
Jain, R. K., Vakil, D., Cunningham, C., & Sidhu, K. (2019) · Journal of Stem Cell Therapy and Transplantation · doi:10.29328/journal.jsctt.1001016 · Cited by 4
Hardiany, N. S., Yo, E. C., Ngadiono, E., & Wanandi, S. I. (2019) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2019.26.6.4 · Cited by 4
“These bioactive factors include certain cytokines, growth factors, chemokines, microRNAs and other protein groups that regulate various physiological processes (6).”
BackgroundGoodman, R. R., & Davies, J. E. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12866 · Cited by 4
Centurione, L., Centurione, M. A., Antonucci, I., Sancilio, S., Stati, G., Stuppia, L., & Pietro, R. D. (2020) · Histochemistry and Cell Biology · doi:10.1007/s00418-020-01940-3 · Cited by 4
Mezhevikina, L. M., Reshetnikov, D. A., Fomkina, M. G., Appazov, N. O., Ibadullayeva, S. Z., & Fesenko, E. E. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06517 · Cited by 4
“Mesenchymal stromal cells (MSCs) of bone marrow, adipose tissue, umbilical cord and peripheral blood, and other tissues of animals and humans have found use as experimental models of gene and cell-based therapy, as well as medicinal drugs in the treatment of cardiovascular, neurodegenerative, immunity-related and onco…”
BackgroundMüller, T. H. (2021) · Biologics · doi:10.2147/btt.s267281 · Cited by 5
The Secretome Deregulations in a Rat Model of Endotoxemic Shock
Blangy‐Letheule, A., Persello, A., Michelland, S., Cunin, V., Souab, F., Aillerie, V., Dhot, J., Erraud, A., Montnach, J., Seve, M., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6650464 · Cited by 6
Nurhayati, R. W., Lubis, D. S. H., Pratama, G., Agustina, E., Khoiriyah, Z., Alawiyah, K., & Pawitan, J. A. (2021) · International Journal of Technology · doi:10.14716/ijtech.v12i6.5172 · Cited by 4
Role of secretome mesenchymal stem cells as immunomodulator in periodontal diseases
Sari, D. S., Maduratna, E., Bumi, C., Sudiana, I. K., & Rantam, F. A. (2021) · Journal of Dentomaxillofacial Science · doi:10.15562/jdmfs.v6i3.989 · Cited by 4
Atiyeh, B. S., & Emsieh, S. (2022) · Aesthetic Plastic Surgery · doi:10.1007/s00266-022-03211-z · Cited by 4
“Due to the vast array of bioactive factors which may potentially affect both local and systemic physiological processes, secretomes are capable of triggering regeneration and repair as well as mediating de novo organogenesis [1].”
BackgroundInfluentialMuscle Spindle Density of Lateral Rotators of the Thigh in Japanese Macaques and a Gibbon
Takeuchi, S., Hirasaki, E., & Kumakura, H. (2019) · Cells Tissues Organs · doi:10.1159/000504958 · Cited by 5
Vizoso, F. J., Fernández-Francos, S., & Eiró, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168395 · Cited by 4
“Moreover, secretome for therapies can be prepared in large quantities ahead of time and be available for therapy if required [10].”
BackgroundSelf-citationWicaksono, S., Rahmahani, J., Ernawati, D. S., Rantam, F. A., Budhy, T. I., Nugraha, A. P., Nur, R. M., Indrastie, N., Ramadhani, N. F., & Noor, T. N. E. B. T. A. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00223 · Cited by 3
Effect of controlled release of HGF on extracellular vesicle secretion by urine-derived stem cells
Alwan, A., Khalil, F., Bowlby, J. J., Peko, G., Estrada, E. V., Singh, S., Deep, G., Zhang, Y., Farney, A. C., & Opara, E. C. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1436296 · Cited by 3
“They have potential as a ready-to-use off-the-shelf biologic product, albeit regulatory requirements for manufacturing and quality control will be necessary to establish the safety and ef fi cacy pro fi le of these products (Vizoso et al., 2017).”
BackgroundCao, Y., Huang, J., Fan, X., & Dai, Y. (2024) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x329310241206105808 · Cited by 3
“The dosage, titer, and safety of exosomes can be evaluated similarly to conventional drugs, thereby facilitating their clinical application [85].”
Stem Cell-Based Therapies for Glaucoma Treatment: A Review Bridging the Gap in Veterinary Patients
Moreira, A. D. S., Lopes, B., Sousa, A. C., Coelho, A. F., Sousa, P., Araújo, A., Delgado, E., Alvites, R., & Maurício, A. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010232 · Cited by 5
Huang, T., Naruphontjirakul, P., Tseng, S.-C., & Su, W. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.031 · Cited by 3
Wang, W., Liu, Y., Zhou, Z., Pang, K., Wang, J.-K., Huan, P.-F., Lu, J., Zhu, T., Zhu, Z., & Han, C.-H. (2025) · Asian Journal of Andrology · doi:10.4103/aja2024115 · Cited by 4
Cheng, F., Chen, X., & Liao, Y. (2025) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2025.11470/2025 · Cited by 3
Carbone-Schellman, J., Fontecilla-Escobar, J., Sales-Salinas, N., Chaparro-Pico, W. F., Molina‐Berríos, A., Ruete, M. C., González, P. A., Machuca, M. A., Opazo, M. C., Ezquer, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1677433 · Cited by 3
Ventura, A., Libonati, A., Marcozzi, S., Ucci, M. A., Salvatore, G., Galgani, A., Pirro, S., Massimiani, M., Picozza, M., Russo, R., et al. (2025) · Biology Direct · doi:10.1186/s13062-025-00697-w · Cited by 7
Leone, N., Andréoli, F., Migliari, M., Guerra, F., Sperduti, S., Casarini, L., Silingardi, R., & Gennai, S. (2025) · International Wound Journal · doi:10.1111/iwj.70784 · Cited by 3
“Among these, mesenchymal stem cell (MSC)- based therapies have emerged as promising strategies to improve the healing process because of their ability to home towards the wound and release potent bioactive factors that can enhance the wound healing process [10–12].”
Telomerase-active urine-derived stem cells: Regenerative solutions for aging
Cheng, X., Fu, Q.-Y., Zheng, Y., Moiseyev, G. P., Hsu, F., Ma, J., Li, Q., Atala, A., & Zhang, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102939 · Cited by 5
Kim, J., Lee, H. J., Chang, P.-S., Lee, J. M., & Kim, J. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.12.008 · Cited by 3
Daňková, V., Exnerová, A., Vágnerová, H., Pavlík, V., & Nešporová, K. (2025) · Biomolecules · doi:10.3390/biom16010002 · Cited by 4
“Secretome-based therapies offer several advantages, including easier storage and handling, lower immunogenic risk, and reduced regulatory complexity [4].”
Shu, J., Liang, Q. N., He, X., Zeng, C., Huang, Y. N., Liu, F., Xu, F., Yong, X. N., & Xie, Y. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl43790 · Cited by 4
Biomimetic nanomaterial-based strategies for spinal cord injury repair
Chen, R.-L., Jiang, L., Teng, H.-B., Yang, J.-L., He, W.-B., Zhang, Y., Ren, Q.-Q., Chen, H.-X., Fan, R., & Xu, J.-G. (2026) · Nano Today · doi:10.1016/j.nantod.2025.102969 · Cited by 3
Critical evaluation of compositions and clinical relevance of Wharton’s jelly-derived biologics
Marleau, A. M., Pearl, J. R., Juárez, P., Almeida, P., Miguel, S., Félix, E. O., Marincola, F. M., West, R., Howard, L., Guerena, D., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07612-x · Cited by 3
Nethaji, K., Shibili, P. A., Dey, A., Nambidi, S., Banerjee, A., Barbon, S., Pathak, S., & Duttaroy, A. K. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.01.006 · Cited by 5
Habib, S. M., Martini, M. F., Abu-Hamdan, Y. N. H., Shrebaty, O. M. M., & Haider, K. H. (2026) · World Journal of Stem Cells · doi:10.4252/wjsc.v18.i3.113871 · Cited by 3
Dangerfield, J. A., & Metzner, C. (2026) · Biomedicines · doi:10.3390/biomedicines14040854 · Cited by 3
Lei, J., Xu, Z., Li, S., LI, M., Wang, Z., Li, P., Wang, J., Chen, Y., Song, X., REN, C., et al. (2021) · Biocell · doi:10.32604/biocell.2021.014569 · Cited by 3
“Moreover, the application of exosomes could avoid several risks such as tumorigenicity, emboli formation, immune compatibility, and infection transmission (Vizoso et al., 2017).”
BackgroundInfluentialMesenchymal stem cells derived secretome as an innovative cell-free therapeutic approach
Abu‐El‐Rub, E., Khasawneh, R. R., Almahasneh, F. A., & Zegallai, H. M. (2021) · Biocell · doi:10.32604/biocell.2022.018306 · Cited by 3
Trends in Adipose-Derived Stem Cell-Conditioned Medium: A Bibliometric and Visualized Review
Yu, C., & Liu, G. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0107 · Cited by 3
“Another influential reference in the later period—Vizoso et al.—was about ‘‘human dermal microvascular endothelial cell’’ (cluster #5), and both Kapur and Katz and Pawitan JA (2014) about ‘‘asc spheroid geometry’’ (cluster #4).”
InfluentialMesenchymal stem cell secretome therapy on inflammation: A systematic review
Sari, M. I., Jusuf, N. K., Munir, D., Putra, A., Putra, I. B., Bisri, T., Farhat, F., Ilyas, S., & Muhar, A. M. (2023) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres23.1726_12.1.39 · Cited by 4
A Comprehensive Review of Stem Cell Conditioned Media Role for Anti-Aging on Skin
Alquraisy, A., Wilar, G., Mohammed, A. F. A., El‐Rayyes, A., Suhandi, C., & Wathoni, N. (2024) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s480437 · Cited by 4
“98 Storage temperatures must always be low, and storage times must be relatively short.”
BackgroundKamar, S. A., Hamdy, K. N., El-Nefiawy, N. E., Mohammed, H., & Fetouh, M. A. (2024) · Cells Tissues Organs · doi:10.1159/000542547 · Cited by 3
Prasetyaningrum, N., Ridwаn, R. D., Saskianti, T., Rachmawati, D., & Virgirinia, R. P. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00820 · Cited by 3
Hussain, Z. (2025) · Exploration of Digestive Diseases · doi:10.37349/edd.2025.100563 · Cited by 3
Yoon, J., Quang, B. D., Shin, J., Kim, J., Lee, J. H., Kim, H., & Lee, J. (2025) · Cells · doi:10.3390/cells14040316 · Cited by 3
Wang, K., Chang, Y., & Ding, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-08686-9 · Cited by 4
“IL9 33 .”
Yang, R., Zhao, D., Wei, H.-X., Chen, S., Yang, Y., Yang, K., Yan, W., & Zhang, T. (2025) · European journal of medical research · doi:10.1186/s40001-025-02814-x · Cited by 4
An effective approach to cartilage regeneration using antler stem cell-conditioned medium
Zhou, J., Xing, B., Guo, Q., Zhao, J., Li, X., Wang, D., Yue, Z., Lv, J., Jiang, Y., & Sun, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-13841-3 · Cited by 5
“It is also convenient to produce in large quantities, making it more economical and practical for clinical applications 23 .”
STEM CELL TECHNOLOGY IN PERIPHERAL NERVE RESTORATION
Petriv, T. I., Tsymbalyuk, Y., Potapov, O. O., Kvasnitsʹkyy, M. V., Honcharuk, O. O., & Tatarchuk, M. M. (2020) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2020;8(2):210-229 · Cited by 3
Cen, W., Umrath, F., Salgado, A. J., Reinert, S., & Alexander, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1024509 · Cited by 3
Zhang, T., Shi, X., Li, M., Hu, J., & Lü, H. (2024) · The American Journal of Sports Medicine · doi:10.1177/03635465231210950 · Cited by 3
“11,50 Our team has developed effective cell-free transplantation strategies by modifying the ECM with recombinant collagen affinity stromal cell–derived factor-1 a (C-SDF1 a ), to give grafts the ability to recruit stem cells into the healing site.”
MethodImmunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line
Emami Meybodi, S. M., Moradi Moraddahande, F., & Dehghani Firoozabadi, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29858 · Cited by 3
“MSCs can be derived from different sources, including bone marrow, placenta, umbilical cord, peripheral blood, and adipose tissues [13,14].”
BackgroundPAI‐1 transfected‐conditioned media promotes osteogenic differentiation of hBMSCs
Li, Z., Kegui, H., Piao, W., Xuejiu, W., Lim, K., & Hexiu, J. (2024) · Cell Biology International · doi:10.1002/cbin.12166 · Cited by 3
“CM is frequently utilized in diverse areas of regenerative medicine and holds therapeutic potential for bone repair in humans (Kumar et al., 2019; Vizoso et al., 2017).”
BackgroundBaradaran, B., Hazrati, A., Kazemi-Sefat, N. A., Soleimanjahi, H., & Soudi, S. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102699 · Cited by 3
Kurniawan, A., Dilogo, I. H., Pawitan, J. A., Widodo, W., Oesman, I., & Martinus, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310467 · Cited by 3
“Besides the secretome enhanced the peripheral nerve regeneration relative comparably to the autograft, the use of secretome had several advantages compared to MSC including [26,27]: a.”
Cell-Free Therapies: Revolutionizing the Approach to Cellular Treatments
Sreenivas, A., & Jha, D. K. (2025) · Biomedical engineering · doi:10.5772/intechopen.1008700 · Cited by 4
Zilberman-Itskovich, S., Sova, M., Hamad, R. A., Frage, N., Esawi, S., Stark, M., Neuman, S., Sela-Tzuriano, L., Slavin, S., & Efrati, S. (2025) · Cureus · doi:10.7759/cureus.84411 · Cited by 4
“Therefore, non-cellular therapies, such as EV treatment, are anticipated to have a safer long-term profile [60,61].”
Applications of the stem cell secretome in regenerative medicine
Mendes-Pinheiro, B., Marote, A., Marques, C. R., Teixeira, F. G., Ribeiro, J. C., & Salgado, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819713-4.00005-0 · Cited by 7
Budiariati, V., Rinendyaputri, R., Noviantari, A., Budiono, D., Fahrudin, M., Juliandi, B., & Boediono, A. (2019) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1502008 · Cited by 3
Imberti, B., Cerullo, D., Corna, D., Rota, C., Locatelli, M., Pezzotta, A., Introna, M., Capelli, C., Carminati, C. E., Rabelink, T. J., et al. (2020) · Cell Transplantation · doi:10.1177/0963689720965467 · Cited by 4
Lara, M. L., Carvalho, M. G., de Souza, F. F., Schmith, R. A., Codognoto, V. M., Vita, B. D., Freitas‐Dell’Aqua, C. D. P., Landim, F. D. C., & Alvarenga, M. L. (2023) · Biochimie · doi:10.1016/j.biochi.2023.03.004 · Cited by 3
McCartan, R., Gratkowski, A., Browning, M., Hahn-Townsend, C., Ferguson, S., Morin, A., Bachmeier, C. J., Pearson, A., Brown, L. R., MULLAN, M. J., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.04.002 · Cited by 3
“Cell-free therapies havebecome a topic of interest in the development of new therapeutics.(16) Both preclinical and clinical studies have shown the anti-inflammatory and anti-apoptotic therapeutic potential of ST266 (formerly ACCS, amnion-derived cellular cytokine solution), a biologic solution containing secreted pro…”
BackgroundNew trends in the regenerative therapy of vitiligo. Literature review
Olisova, O. Y., Timashev, P. S., Pishulina, E. V., Semiklet, J. M., Бердникова, Е. А., Игоревна, К. П., & Lomonosov, K. M. (2023) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv295040 · Cited by 3
Sorokovikova, T. V., Morozov, A. M., Kryukova, A. N., Naumova, S. A., & Belyak, M. A. (2023) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2023.4.tx.3 · Cited by 3
Zhang, H., Zhang, Y., Qiu, C., Zhu, W.-T., Wen, M., & Lao, X. (2021) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2021.1961608 · Cited by 3
Krane, N. A., Christofides, E. A., & Halaas, Y. P. (2021) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-021-00368-0 · Cited by 3
Stem Cell-Derived Exosome Therapy for Dental Diseases: From Bench to Bed in Dentistry
Jasser, R. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164991 · Cited by 3
Exploring the Secretome’s Biomarker and Analgesic Potential
Hershfield, M. R., Strain, M. M., Chavez, R., Priess, M., Mares, A., Gautam, A., Dimitrov, G., Yang, R., Trevino, A. V., Wells, C. K., et al. (2022) · American Journal of Psychiatry and Neuroscience · doi:10.11648/j.ajpn.20221002.12 · Cited by 3
Cell Therapy: A Therapeutic Option for Multiple Sclerosis
Khojasteh, M. R., Razavi, A. S., Javadzadeh, A., Gorji, A., & Negah, S. S. (2018) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.6.3.52 · Cited by 3
Advances in Regenerative Medicine: From Stem Cells to Organoids
Pawitan, J. A. (2018) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2018.612012 · Cited by 3
“Therefore, there are attempts to produce stem cell secretomes/metabolites to replace the stem cells themselves [7].”
BackgroundInfluentialStem cell secretome attenuates acute rejection in rat lung allotransplant
Pieróg, J., Fytianos, K., Tamò, L., Simillion, C., Taddeo, A., Kocher, G. J., Gugger, M., Grodzki, T., Heller, M., Blank, F., et al. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy306 · Cited by 3
António, N. (2019) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2019.10.003 · Cited by 3
Pinheiro, B. F. M., Anjo, S. I., Manadas, B. J., Silva, J. D. D., Marote, A., Behie, L. A., Teixeira, F. G., & Salgado, A. J. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3417858 · Cited by 4
Silva, C. S., Casanova, M. R., Ferreirinha, P., Morais, A. D. S., Osório, H., Lima, A. C., Fangueiro, J. F., Cerqueira, M. T., Reis, R. L., Alves, N. L., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2024.123366 · Cited by 2
Morte, E. D., Notarangelo, M. P., Niada, S., Giannasi, C., Fortuna, F., Cadelano, F., Lambertini, E., Piva, R., Brini, A. T., & Penolazzi, L. (2025) · Calcified Tissue International · doi:10.1007/s00223-024-01335-9 · Cited by 2
“These advantages include enhanced safety, ease of storage, less-invasive administration, scalability, cost-effectiveness, immediate availability, and customizable therapeutic effects [19].”
Katahira, Y., Horio, E., Yamaguchi, N., Sonoda, J., Yamagishi, M., Miyakawa, S., Murakami, F., Hasegawa, H., Mizoguchi, I., & Yoshimoto, T. (2025) · Antioxidants · doi:10.3390/antiox14010109 · Cited by 2
Darzenta, N., Davis, E., Cochran, A. M., Murray, M., Moore, O., & Naskou, M. C. (2025) · Stem Cells and Development · doi:10.1089/scd.2025.0042 · Cited by 2
“5,6 The therapeutic effect of stem cell-derived EVs has been explored against a variety of neurological diseases, including Alzheimer ’ s disease, 13 traumatic brain injury, 14,15 graft-versus-host disease, 16 thromboembolic stroke, 17 ischemic stroke, 11 multiple sclerosis, 18 Parkinson ’ s…”
Kim, H.-G., Moon, Y. S., & Sohn, D. (2025) · Journal of Functional Biomaterials · doi:10.3390/jfb16070251 · Cited by 2
“Additionally, it has been noted that MSC-CM exhibits significant bone regeneration potential even at low doses, thanks to the collaborative impact of growth factors [15,17,32,36].”
Nugraha, A. P., Yang, K., Pramusita, A., Putranti, N. A. R., Luthfi, M., Ramadhani, N. F., Sitalaksmi, R. M., Situmorang, P. C., Artasasta, M. A., Alhasyimi, A. A., et al. (2025) · Journal of Dental Sciences · doi:10.1016/j.jds.2025.07.003 · Cited by 3
“26 Various bioactive factors that are released from the MSC secretome consist of indoleamine 2,3-dioxygenase (IDO), prostaglandin-E2 (PGE2), IL-4, IL-10, IL-12, and hepatocyte growth factor (HGF) that can be harvested by isolating their culture medium contained in the MSCs and have the capacity to…”
Deng, Q., Huang, J., Tsang, L. L., Guo, J., Wang, C. C., Zhang, X., & Jiang, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146888 · Cited by 3
“Recent advances have further emphasized the therapeutic potential of the MSC-derived secretome, defined as the complete repertoire of bioactive molecules secreted by MSCs [16].”
Griffin, K. H., Sagheb, I. S., Coonan, T. P., Wu, L., Rowland, D. J., Arzi, B., Lewis, J. S., & Leach, J. K. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502466 · Cited by 2
Najeb, M., Samy, A., Rizk, A., Mosbah, E., & Karrouf, G. (2025) · Irish Veterinary Journal · doi:10.1186/s13620-025-00309-z · Cited by 2
“The therapeutic effects of MSCs appear to be primarily mediated through paracrine mechanisms rather than direct cellular replacement [136, 137].”
Mateo, J., Suárez-Suárez, M. A., Fraile, M., Piñera-Parrilla, Á., Vizoso, F. J., & Eiró, N. (2025) · Biomolecules · doi:10.3390/biom15101402 · Cited by 2
“The time and expenses associated with the expansion and upkeep of cultured stem cells can be significantly minimized, allowing for the immediate availability of secretome therapies for urgent conditions such as cerebral ischemia [46].”
Self-citationNugraha, D. K., Jutadi, Anggoro, N. S., Sari, F. N., & Ardani, Y. (2025) · International Journal of Cell and Biomedical Science · doi:10.59278/cbs.v4i10.66 · Cited by 2
Nugraha, D. K., & Falah, A. (2025) · International Journal of Cell and Biomedical Science · doi:10.59278/cbs.v3i9.61 · Cited by 2
“These vesicular components encapsulate proteins, lipids, messenger ribonucleic acids (mRNAs), and microRNAs 20 .”
Chen, M., Tang, J., Liang, B., Feng, G., Deng, Z., Chen, S., Sun, Q., Liu, J., & Chen, X. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.10.026 · Cited by 2
Kantapan, J., Innuan, P., Sirikul, C., Anukul, N., Rolin, G., & Dechsupa, N. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102338 · Cited by 3
“Delivering conditioned medium (CM) — the cell-free form of the secretome — captures the key paracrine activities of cell therapies while avoiding major hurdles of live-cell delivery such as immune incompatibility, tumorigenicity, poor engraftment, and stringent handling [9,10].”
Jin, X., & Liu, Z. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1729698 · Cited by 3
“Exo are considered micromodel of their parent cells, partly because they carry a unique set of biomolecules from the parent cells (7), but without the side effects associated with the parent cells (8).”
Quintero-Gil, C., Jaraba-Álvarez, W. V., Franco-Salazar, J. P., Blanquiceth, Y., Bedoya-Guzmán, F. A., Ortiz-Tamayo, S., Quiroz-Correa, N., Sanchez-Giraldo, V., Halpert-Correa, K., & Ortega-Arellano, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1692585 · Cited by 2
“Mesenchymal stromal cells (MSCs) have emerged as a cornerstone of regenerative medicine due to their capacity to secrete bioactive factors that modulate inflammation, promote tissue repair, and support overall regeneration (1).”
Mesenchymal stem cells reverse disease-specific abnormalities in nociceptive regions of the brain
Fukushi, R., Sasaki, M., Obara, H., Kurihara, K., Hirota, R., Morita, T., Teramoto, A., Yamashita, T., Tan, A. M., Waxman, S. G., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf494 · Cited by 2
“It has been re-ported that infused MSCs orchestrate a process that includes neuroprotection, stabilization of the disrupted blood–spinal cord barrier, angiogenesis, remyelination, axonal regeneration, remote effects, induction of neural plasticity, 28 neu-roimmune 29 and secretome 30 modulation.”
Serhal, N., Brassart, B., Nannan, L., Audonnet, S., Tournois, C., Poitevin, G., Cornillet‐Lefèbvre, P., Dubuisson, F., Peyret, H., Nguyên, P., et al. (2026) · Journal of Extracellular Biology · doi:10.1002/jex2.70105 · Cited by 2
“Cell therapy using MSCs is based on the concept that, once injected, MSCs can migrate, proliferate in areas of ischemia, and promote regeneration of damaged tissues (Vizoso et al. 2017 ).”
Abdallah, A. N., Effat, H., Mousbah, A. M., Ahmed, H. H., & Abohashem, R. S. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70705 · Cited by 3
“Exosomes are nanoscale, spherical, and lipid bi‐layered single membrane extracellular vesicles, which act as intercellular messengers [18].”
Wharton's jelly mesenchymal stem cell-secretome enhances skin rejuvenation via ApoA4 and SERPINH1
Lee, N. E., Hwang, J. I., Bang, C. Y., Kim, E. H., & Bang, O. Y. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101071 · Cited by 2
“From a regenerative perspective, mesenchymal stromal cell (MSC)-derived secretome factors drive paracrine remodeling of the extracellular matrix, stimulating fibroblast proliferation, promoting microvascular network formation, and supporting comprehensive tissue repair [10 – 12].”
Advances in Parkinson's disease management using umbilical cord-derived mesenchymal stem cells
Mante, N., Undale, V., Sanap, A. P., Bhonde, R. R., Kheur, S. M., Tambe, P., & Kharat, A. H. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578911 · Cited by 2
iMSCs vs MSCs: Comparative Features and Therapeutic Potential in Wound Healing
Sanap, A. P., Ashok, A., Raundal, K., Kheur, S. M., Badhe, R. V., & Bhonde, R. R. (2026) · Advanced Biology · doi:10.1002/adbi.202500623 · Cited by 2
Luo, D., Feng, E., Chen, L., Ni, K., Luo, S., Ma, L., Wu, Y., Hu, Z., Lin, D., Zhang, B., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70834 · Cited by 2
Ghasemi, D., Ghahremani‐Nasab, M., Barzegari, A., Khalili, A. F., & Bakhshayesh, A. R. D. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103547 · Cited by 2
Long, S., Wang, B., Tian, S., Tang, H., Wu, H., Yang, X., & Zhang, C. (2026) · Pharmaceuticals · doi:10.3390/ph19050672 · Cited by 3
“In this context, exosomes, as the “messengers” through which stem cells exert their paracrine functions, are spearheading a paradigm shift towards “cell-free therapy” [1–4].”
Regenerative Medicine Approaches to Craniofacial and Corneal Neuropathic Pain
Liongson, F. A. Z., Yoo, J., Swett, B. J., Falowski, S. M., Pope, J., Sayed, D., Deer, T., Hasoon, J. J., Keith, D. A., Guastaldi, F. P. S., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19050692 · Cited by 2
“These cells modulate the local milieu and support nerve repair through paracrine activity and extracellular vesicle release [25].”
Ibrahim, R. M., & Houreld, N. N. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119440 · Cited by 2
Khoo, L., Chin, Y. Z., & Law, J. X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s598256 · Cited by 2
“89,90 Additionally, MSC-EVs carry specific miRNAs such as miR-21-3p, miR-125a, and miR-126-3p that regulate wound healing pathways.”
Zhou, T., Huang, X., Tan, Y., Shen, J., Zhou, X., 李贵刚, & Wang, W. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111049 · Cited by 2
Prodromos, C. C., Villar, R. D., Striegel, A., Pena, G. R., & Dixit, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104483 · Cited by 4
Liu, J., He, L., Li, C., Feng, Q., Yu, Y., Wei, L., & Zheng, H. (2026) · Materials & Design · doi:10.1016/j.matdes.2026.116298 · Cited by 2
Metadata
- Authors
- Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R.
- Affiliations
- Fundación Hospital de Jove (ES)
- Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33290 Gijón, Spain
- Department of Obstetrics & Gynecology, C/Ramon y Cajal 7, University of Valladolid, 47005 Valladolid, Spain
- Department of Physiology-Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Santiago de Compostela, Spain
- Corresponding author
- Vizoso, Francisco
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-08-25
- Volume
- 18
- Issue
- 9
- Pages
- 1852
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5618501
- OpenAlex
- W2746710261
- Cited by
- 1,363
- References
- 235
- Citations by year
- 2026: 142 · 2025: 165 · 2024: 153 · 2023: 182 · 2022: 186 · 2021: 178 · 2020: 158 · 2019: 130 · 2018: 62 · 2017: 6
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Council
- European Regional Development Fund (SAF2015-69221-R)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- mesenchymal stem cells, secretome, cell-free therapy, conditioned medium, exosomes, regenerative medicine, stem cell therapy, quality control, regulatory requirements
- MeSH terms
- Clinical Studies as Topic, Animals, Humans, Stem Cells, Culture Media, Conditioned, Regenerative Medicine, Mesenchymal Stem Cell Transplantation, Cell-Derived Microparticles, Exosomes, Mesenchymal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.